Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

10X GENOMICS, INC.

(TXG)
  Report
Delayed Quote. Delayed Nasdaq - 01/20 04:00:00 pm
93.03 USD   +3.78%
01/14INSIDER SELL : 10x Genomics
MT
01/07INSIDER SELL : 10x Genomics
MT
01/05INSIDER SELL : 10x Genomics
MT
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
01/13/2022 01/14/2022 01/18/2022 01/19/2022 01/20/2022 Date
104.82(c) 104(c) 92.69(c) 89.64(c) 93.03 Last
2 447 684 2 044 219 1 233 609 1 110 523 1 325 302 Volume
-11.78% -0.78% -10.88% -3.29% +3.78% Change
More quotes
Estimated financial data (e) (USD)
Sales 2021 494 M - -
Net income 2021 -46,2 M - -
Net cash position 2021 488 M - -
P/E ratio 2021 -196x
Yield 2021 -
Sales 2022 679 M - -
Net income 2022 -13,7 M - -
Net cash position 2022 411 M - -
P/E ratio 2022 -378x
Yield 2022 -
Capitalization 10 013 M 10 013 M -
EV / Sales 2021 19,3x
EV / Sales 2022 14,1x
Nbr of Employees 1 148
Free-Float -
More Financials
Company
10x Genomics, Inc. is a life science technology company. The CompanyÔÇÖs integrated solutions include instruments, consumables and software for analyzing biological systems at a resolution and scale that matches the complexity of biology. The CompanyÔÇÖs product consists of chromium single cell gene expression solution, cell immune profiling solution, cell copy number variation (CNV) solution, Cell assay for... 
More about the company
Ratings of 10x Genomics, Inc.
Trading Rating : 
Investor Rating : 
ESG Refinitiv : 
C-
More Ratings
All news about 10X GENOMICS, INC.
01/14INSIDER SELL : 10x Genomics
MT
01/07INSIDER SELL : 10x Genomics
MT
01/05INSIDER SELL : 10x Genomics
MT
202110x Genomics to Present Virtually at the 40th Annual J.P. Morgan Healthcare Conference
PR
2021INSIDER SELL : 10x Genomics
MT
2021INSIDER SELL : 10x Genomics
MT
2021INSIDER SELL : 10x Genomics
MT
202110x Genomics Recognized on The Scientist's Top 10 Innovations List for Fifth Consecutiv..
PR
2021INSIDER SELL : 10x Genomics
MT
2021INSIDER SELL : 10x Genomics
MT
202110X GENOMICS, INC. Management's Discussion and Analysis of Financial Condition and Res..
AQ
2021Health Care Stocks Struggle Throughout Thursday Session
MT
2021Morgan Stanley Adjusts Price Target on 10x Genomics to $205 from $215, Keeps Overweight..
MT
2021Health Care Stocks Losing Ground on Thursday
MT
2021INSIDER SELL : 10x Genomics
MT
More news
News in other languages on 10X GENOMICS, INC.
01/14VENTE D'INITIÉS : 10x Genomics
01/05VENTE D'INITIÉS : 10x Genomics
2021VENTE D'INITIÉS : 10x Genomics
2021Les actions du secteur de la santé perdent du terrain jeudi
2021VENTE D'INITIÉS : 10x Genomics
More news
Analyst Recommendations on 10X GENOMICS, INC.
More recommendations
Chart 10X GENOMICS, INC.
Duration : Period :
10x Genomics, Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends 10X GENOMICS, INC.
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 8
Last Close Price 89,64 $
Average target price 190,00 $
Spread / Average Target 112%
EPS Revisions
Managers and Directors
Serge Saxonov Chief Executive Officer & Director
Benjamin J. Hindson Director
Justin J. McAnear Chief Financial & Accounting Officer
John R. Stuelpnagel Chairman
Michael Schnal-Levin Senior Vice President-Research & Development
Sector and Competitors